Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CSA Z314.9-09 (2013) – Biological Indicators for Sterilization: Selection, Use, and Interpretation Guidance
A comprehensive overview of the Canadian standard for biological indicator practices in health care settings
Scope and Purpose
CSA Z314.9-09 (2013) – Sterilization of health care products — Biological indicators — Guidance for the selection, use and interpretation of results is a key document in the CSA Z314 series, which addresses sterilization practices in Canadian health care facilities. This standard provides comprehensive recommendations for health care personnel responsible for sterilizing medical devices, focusing on the appropriate selection, handling, placement, incubation, and interpretation of biological indicators (BIs). While aligned with international principles from the ISO 11138 series, CSA Z314.9-09 (2013) incorporates specific Canadian regulatory contexts and practical constraints encountered in hospitals and clinics. The standard applies to all sterilization modalities commonly used in health care, including steam (moist heat), ethylene oxide (EtO), hydrogen peroxide gas plasma, and low-temperature formaldehyde steam. Its primary goal is to ensure that BIs are used effectively as part of a robust sterilization assurance program, enabling timely detection of process failures and reducing the risk of health care‑associated infections.
Technical Requirements
Types of Biological Indicators
The standard classifies biological indicators based on the sterilization process for which they are intended. Each BI comprises a carrier (e.g., paper, glass, plastic) inoculated with a known concentration of highly resistant spores. The choice of microorganism must reflect the resistance characteristics required for the specific sterilization method. Table 1 summarizes the most common BI types addressed in the standard.
| Sterilization Process | Recommended Microorganism | Typical Carrier | Incubation Conditions |
|---|---|---|---|
| Steam (moist heat) | Geobacillus stearothermophilus ATCC 7953 | Paper strips, self‑contained ampoules, or plastic cassettes | 55–60 °C / 7 days (rapid readout: 1–3 hours) |
| Ethylene Oxide (EtO) | Bacillus atrophaeus ATCC 9372 | Paper strips or porous pouches | 35–37 °C / 7 days |
| Hydrogen Peroxide Gas Plasma | Geobacillus stearothermophilus ATCC 7953 | Self‑contained ampoules with stainless steel carriers | 55–60 °C / 7 days (rapid readout: 4–8 hours) |
| Low‑Temperature Formaldehyde Steam | Geobacillus stearothermophilus ATCC 7953 | Paper discs or polypropylene vials | 55–60 °C / 10 days |
Tip: Always consult the BI manufacturer’s product specification sheet for exact incubation times and temperature tolerances. Rapid‑readout BIs can provide results in hours, but they must be validated for each sterilizer cycle.
Selection Criteria
CSA Z314.9-09 (2013) requires that BIs be selected based on the specific sterilization process and the intended load configuration. Key selection factors include: the type of sterilizer (e.g., dynamic air removal vs. gravity displacement); the nature of the items being sterilized (e.g., porous loads, wrapped instruments, liquids); and the cycle parameters (temperature, exposure time, sterilant concentration). The standard also emphasizes that BIs should have a known and documented resistance that exceeds the bioburden of the devices being sterilized. Where possible, BIs should be self‑contained to reduce cross‑contamination risk.
Warning: A biological indicator result that is positive does not automatically indicate sterilizer malfunction. Improper loading, inadequate air removal, incorrect BI placement, or mishandling during incubation can produce false‑positive readings. Investigate systematically.
Placement and Exposure
The standard recommends placing BIs inside test packs that mimic the most difficult‑to‑sterilize item routinely processed in the load. For steam cycles, the test pack should be placed in the most challenging location within the chamber, usually the lower front (near the drain) or in the center of the load if it is a porous pack. For EtO or other low‑temperature processes, BIs must be positioned where sterilant penetration is least effective (e.g., inside lumened devices or wrapped trays). The number of BIs per load is based on chamber volume and risk assessment; a minimum of one BI per cycle is typical for routine monitoring, with additional BIs used for qualification (IQ/OQ/PQ).
Incubation and Interpretation
After exposure, BIs are incubated under conditions specified for the microorganism. CSA Z314.9-09 (2013) provides detailed instructions for reading and interpreting both growth‑based and enzyme‑based (rapid readout) systems. Growth‑based BIs require visual detection of turbidity or pH color change after a defined incubation period (e.g., 7 days). Rapid‑readout BIs utilize a fluorogenic substrate that detects spore enzyme activity, often producing a result in 1–8 hours, but the standard warns that these may not completely replace full‑duration incubation for final release decisions. A negative BI (no growth or no enzyme activity) indicates that the sterilization conditions were sufficient to inactivate the challenge spores. A positive BI (growth or enzyme activity) indicates that the process has likely failed to achieve the required sterility assurance level (SAL). In such cases, the standard mandates that the load be quarantined and not used until the source of failure is identified and corrected. Repeat testing with a fresh BI and chemical indicators is required.
Implementation Highlights
Adopting CSA Z314.9-09 (2013) in a health care facility requires coordination among sterile processing, infection control, and quality assurance teams. The standard emphasizes the need for written policies and procedures covering: BI procurement, storage, handling, and disposition; routine monitoring frequency (which should be at least once per day for each sterilizer in use, or per each load for implantable devices); and corrective actions following positive results. Facilities must also validate the performance of BIs under local conditions—e.g., using the same loading pattern and cycle parameters as those used for clinical loads. Staff training is critical, as incorrect interpretation of rapid‑readout BIs can lead to premature release of non‑sterile items. The standard encourages the use of process challenge devices (PCDs) in combination with BIs for enhanced assurance.
Best Practice: Integrate biological indicator testing into a comprehensive sterilization assurance program that also includes chemical indicators, physical monitors (charts, printouts), and routine equipment maintenance. This multifactorial approach reduces the risk of undetected failure.
Compliance and Documentation
In Canada, adherence to CSA Z314.9-09 (2013) is recognized as a reasonable standard of care for sterilization practices and may be referenced during health authority inspections or accreditation surveys (e.g., by Accreditation Canada or the province’s quality council). The standard requires that all biological indicator test results be documented, including: date and cycle number; sterilizer identification; type and lot number of BI; load contents; placement location; incubation conditions; final interpretation (including time to positive if rapid readout); and any corrective actions taken. Records must be retained for a minimum period defined by the facility’s regulatory framework—typically at least three years. The standard also recommends that a positive BI result be reviewed as part of a formal incident investigation, with root cause analysis and implementation of preventive measures. Facilities that outsource sterilization or BI testing must ensure that the contracted service complies with the same requirements specified in the standard.
Frequently Asked Questions
Q: What is the primary purpose of CSA Z314.9-09 (2013)?
A: The standard’s main goal is to provide clear, practical guidance for selecting, using, and interpreting biological indicators in health care sterilization processes. It helps ensure that BIs are employed effectively as a key component of sterilization process monitoring, thereby protecting patients from infections caused by improperly sterilized devices.
A: The standard’s main goal is to provide clear, practical guidance for selecting, using, and interpreting biological indicators in health care sterilization processes. It helps ensure that BIs are employed effectively as a key component of sterilization process monitoring, thereby protecting patients from infections caused by improperly sterilized devices.
Q: How often should biological indicators be used in routine sterilization monitoring?
A: The standard recommends that every sterilizer used in a health care facility be tested with a biological indicator at least once per day of use. For loads containing implantable devices, a BI should be included in every cycle, and the load should be quarantined until the BI result is known (i.e., a negative reading). Additional BIs may be required after major repairs or requalification.
A: The standard recommends that every sterilizer used in a health care facility be tested with a biological indicator at least once per day of use. For loads containing implantable devices, a BI should be included in every cycle, and the load should be quarantined until the BI result is known (i.e., a negative reading). Additional BIs may be required after major repairs or requalification.
Q: Can biological indicators be reused or reprocessed?
A: No. Biological indicators are single‑use devices. Attempting to reuse or reprocess a BI will compromise its spore viability, resistance characteristics, and ability to correctly indicate sterilization failure. The standard explicitly prohibits any form of reuse.
A: No. Biological indicators are single‑use devices. Attempting to reuse or reprocess a BI will compromise its spore viability, resistance characteristics, and ability to correctly indicate sterilization failure. The standard explicitly prohibits any form of reuse.
Q: What should be done if a biological indicator yields a positive result?
A: The load must be immediately quarantined and not used until a comprehensive investigation is completed. Check the sterilizer cycle printout, the chemical indicator performance, and the BI placement and lot number. Repeat the test with a fresh BI and re‑run the cycle. If the repeat cycle shows a negative result, the sterilizer may be returned to service; if positive, suspends use and contact the manufacturer or service provider for corrective action. Document all findings per facility protocol.
A: The load must be immediately quarantined and not used until a comprehensive investigation is completed. Check the sterilizer cycle printout, the chemical indicator performance, and the BI placement and lot number. Repeat the test with a fresh BI and re‑run the cycle. If the repeat cycle shows a negative result, the sterilizer may be returned to service; if positive, suspends use and contact the manufacturer or service provider for corrective action. Document all findings per facility protocol.
— Published: 2026. Based on CSA Z314.9-09 (2013) – Sterilization of health care products — Biological indicators — Guidance for the selection, use and interpretation of results.